Humalog and Combivir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Humalog (insulin lispro recombinant) and Combivir (lamivudine; zidovudine). Common drug interactions include multiple fractures among females and anxiety among males.
The phase IV clinical study analyzes what interactions people have when they take Humalog and Combivir. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.
What is Humalog?
Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.
What is Combivir?
Combivir has active ingredients of lamivudine; zidovudine. It is often used in hiv infection. eHealthMe is studying from 15,450 Combivir users. Check the latest studies of Combivir.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
50 people who take Humalog and Combivir together, and have interactions are studied.

What are the common drug interactions of Humalog and Combivir, by gender? *:
female:
- Multiple fractures
- Osteoporosis (bones weak and more likely to break)
- Renal injury (kidney injury)
- Anxiety
- Chronic kidney disease
- Emotional distress
- Pain
- Bone density decreased
- Cushing's syndrome (obesity, a rounded face, increased fat)
- Depression
male:
- Anxiety
- Emotional distress
- Hyperkalaemia (damage to or disease of the kidney)
- Anaemia (lack of blood)
- Azotaemia (excess of urea or other nitrogenous compounds in the blood)
- Gait disturbance
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Impaired work ability
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Nephrolithiasis (calculi in the kidneys)
What are the common drug interactions of Humalog and Combivir, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Cushing's syndrome (obesity, a rounded face, increased fat)
- Cushingoid (obesity and weakening of the muscles)
- Dexamethasone suppression test positive
40-49:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Emotional distress
- Pain
- Renal failure (kidney dysfunction)
- Renal impairment (severely reduced kidney function)
- Hyperkalaemia (damage to or disease of the kidney)
- Azotaemia (excess of urea or other nitrogenous compounds in the blood)
- Decreased activity
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
50-59:
- Anxiety
- Chronic kidney disease
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Emotional distress
- Pain
- Bone density decreased
- Depression
- Anaemia (lack of blood)
- Back pain
- Gait disturbance
60+:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Dehydration (dryness resulting from the removal of water)
- Dry mouth
- Electrolyte imbalance
- Fatigue (feeling of tiredness)
- Gastritis (inflammation of stomach)
- Herpes simplex (herpes simplex is a common viral infection)
- Hyperglycaemia (high blood sugar)
- Insomnia (sleeplessness)
What are the existing conditions these people have? *
- High Blood Cholesterol: 9 people, 18.00%
- High Blood Pressure: 8 people, 16.00%
- Type 2 Diabetes: 7 people, 14.00%
- Depression: 7 people, 14.00%
- Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 12.00%
- Blood Insulin Abnormal: 5 people, 10.00%
- Diarrhea: 5 people, 10.00%
- Erection Problems: 5 people, 10.00%
- Gastritis (inflammation of stomach): 5 people, 10.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 10.00%
* Approximation only. Some reports may have incomplete information.
Do you take Humalog and Combivir?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Humalog and Combivir:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Humalog:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Combivir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Humalog and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Combivir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on insulin lispro recombinant and lamivudine; zidovudine (the active ingredients of Humalog and Combivir, respectively), and Humalog and Combivir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Miralax and Prednisone - 7 seconds ago
- Could Alecensa cause Dementia? - 10 seconds ago
- Could Carvedilol cause Appetite Decreased? - 13 seconds ago
- Could Carvedilol cause Appetite - Decreased? - 14 seconds ago
- Could Enoxaparin Sodium cause Skin Candida? - 15 seconds ago
- Drug interactions of Opdivo and Adderall - 18 seconds ago
- Could Imdur cause Haematocrit Abnormal? - 20 seconds ago
- Drug interactions of Metoprolol Succinate and Benzonatate - 25 seconds ago
- Could Copaxone cause Multiple Sclerosis? - 25 seconds ago
- Could Claritin cause Bone Marrow Disorder? - 39 seconds ago